BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9165177)

  • 1. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.
    Anker SD; Egerer KR; Volk HD; Kox WJ; Poole-Wilson PA; Coats AJ
    Am J Cardiol; 1997 May; 79(10):1426-30. PubMed ID: 9165177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cytokine parameters and mortality in patients with chronic heart failure.
    Rauchhaus M; Doehner W; Francis DP; Davos C; Kemp M; Liebenthal C; Niebauer J; Hooper J; Volk HD; Coats AJ; Anker SD
    Circulation; 2000 Dec; 102(25):3060-7. PubMed ID: 11120695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.
    Sharma R; Bolger AP; Li W; Davlouros PA; Volk HD; Poole-Wilson PA; Coats AJ; Gatzoulis MA; Anker SD
    Am J Cardiol; 2003 Jul; 92(2):188-93. PubMed ID: 12860222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
    Akanmori BD; Kurtzhals JA; Goka BQ; Adabayeri V; Ofori MF; Nkrumah FK; Behr C; Hviid L
    Eur Cytokine Netw; 2000 Mar; 11(1):113-8. PubMed ID: 10705308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.
    Mwatha JK; Kimani G; Kamau T; Mbugua GG; Ouma JH; Mumo J; Fulford AJ; Jones FM; Butterworth AE; Roberts MB; Dunne DW
    J Immunol; 1998 Feb; 160(4):1992-9. PubMed ID: 9469463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure.
    Peschel T; Schönauer M; Thiele H; Anker SD; Schuler G; Niebauer J
    Eur J Heart Fail; 2003 Oct; 5(5):609-14. PubMed ID: 14607199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?
    Naudin J; Capo C; Giusano B; Mège JL; Azorin JM
    Schizophr Res; 1997 Aug; 26(2-3):227-33. PubMed ID: 9323355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in circulating cytokines after 2 forms of exercise training in chronic stable heart failure.
    LeMaitre JP; Harris S; Fox KA; Denvir M
    Am Heart J; 2004 Jan; 147(1):100-5. PubMed ID: 14691426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of circulating soluble CD14 in Kawasaki disease.
    Takeshita S; Nakatani K; Tsujimoto H; Kawamura Y; Kawase H; Sekine I
    Clin Exp Immunol; 2000 Feb; 119(2):376-81. PubMed ID: 10632678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
    Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
    Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans.
    Kuhns DB; Alvord WG; Gallin JI
    J Infect Dis; 1995 Jan; 171(1):145-52. PubMed ID: 7528250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure.
    Lommi J; Pulkki K; Koskinen P; Näveri H; Leinonen H; Härkönen M; Kupari M
    Eur Heart J; 1997 Oct; 18(10):1620-5. PubMed ID: 9347273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis].
    Tesar V; Jelínková E; Jirsa M; Bakosová N; Pit'ha V; Chábová V
    Cas Lek Cesk; 1998 Nov; 137(21):654-9. PubMed ID: 9929930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange.
    Tesar V; Jelínková E; Jirsa M; Bakosová M; Pitha P; Chábová V
    Blood Purif; 2000; 18(2):115-20. PubMed ID: 10838470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure.
    Genth-Zotz S; von Haehling S; Bolger AP; Kalra PR; Wensel R; Coats AJ; Volk HD; Anker SD
    Eur J Heart Fail; 2006 Jun; 8(4):366-72. PubMed ID: 16337191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF).
    Endo S; Inada K; Kasai T; Takakuwa T; Nakae H; Kikuchi M; Yamashita H; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):17-25. PubMed ID: 7518965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bancroftian filariasis: immunological markers of morbidity and infection.
    Satapathy AK; Sartono E; Sahoo PK; Dentener MA; Michael E; Yazdanbakhsh M; Ravindran B
    Microbes Infect; 2006 Aug; 8(9-10):2414-23. PubMed ID: 16839794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.
    Bolger AP; Anker SD
    Drugs; 2000 Dec; 60(6):1245-57. PubMed ID: 11152010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.